BioProgress plc Announces The OTC Launch Of Sore Throat Treatment, Collunovar For Dexo France

May 15, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BioProgress (AIM: BPRG; NASDAQ: BPRG), the speciality pharmaceutical and healthcare company, today announced that its treatment for sore throats, Collunovar, has been launched in France as an over-the-counter (OTC) medicine.

Twitter
LinkedIn
Facebook
Email
Print

Europe